Abstract | SETTING: A teaching hospital in the Republic of Korea, 2003-2009. OBJECTIVE: To evaluate the effect of previous tuberculosis (TB) treatment history on sputum smear and culture conversion. DESIGN: Data, including sputum acid-fast bacilli (AFB) results at baseline and at weeks 2, 4, 8, 12, 16, 20 and 24, were collected from patients with AFB sputum smear-positive and culture-confirmed pulmonary TB. Patients with multidrug-resistant TB or those with poor adherence were excluded. AFB conversion was compared between patients with a previous history of anti- tuberculosis treatment and those without. RESULTS: The median age of the 208 patients was 49.0 years; 58.3% were male, while 43 (20.7%) had a history of previous anti- tuberculosis treatment. Patients with a history of previous treatment had significantly lower sputum smear-negative conversion at 2 weeks of treatment compared with patients without (70.0% vs. 44.8%, P = 0.005). However, the two groups did not differ in culture conversion and in smear conversion at 4, 8, 12, 16, 20 and 24 weeks of anti- tuberculosis treatment. CONCLUSION: Patients with a history of previous anti- tuberculosis treatment are more likely to have positive sputum AFB smear at 2 weeks of treatment. However, sputum culture conversion is not affected by previous treatment history.
|
Authors | J Lee, B J Lee, H I Yoon, C-T Lee, J H Lee |
Journal | The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
(Int J Tuberc Lung Dis)
Vol. 16
Issue 10
Pg. 1344-8
(Oct 2012)
ISSN: 1815-7920 [Electronic] France |
PMID | 23107634
(Publication Type: Comparative Study, Journal Article)
|
Chemical References |
|
Topics |
- Adult
- Aged
- Antitubercular Agents
(therapeutic use)
- Female
- Humans
- Male
- Middle Aged
- Mycobacterium tuberculosis
(drug effects, isolation & purification)
- Prevalence
- Republic of Korea
(epidemiology)
- Retrospective Studies
- Sputum
(microbiology)
- Treatment Failure
- Tuberculosis, Multidrug-Resistant
(drug therapy, epidemiology, microbiology)
- Tuberculosis, Pulmonary
(drug therapy, epidemiology, microbiology)
|